EUVIMEDEUVIMED entdecken
Crossref

Co‐Delivery of Cisplatin and Curcumin via ROS‐Responsive Nanoparticles to Activate the cGAS‐STING Pathway for Osteosarcoma Metalloimmunotherapy

Yanan Wu, Yuchen Han, Wenchao Li, Xinli Han, Wei Wang, Jingyou Bi, Yinglong Zhang, Dongquan Xiang, Hongqin Gao, Nan Hu, Wenzhi Bi, Jianxiong Li iD

Advanced Healthcare Materials · 2026-03 · 15 (9)

DOI: 10.1002/adhm.202504555 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 03.12.2025. Verfasst von Yanan Wu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Senior Department of Orthopedics, Chinese PLA General Hospital, Beijing, P. R. China. Hauptthemen laut MEDLINE: Nucleotidyltransferases, Osteosarcoma, Nanoparticles, Reactive Oxygen Species. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cisplatin (Cis) is widely recognized as the cornerstone of osteosarcoma (OS) chemotherapy. However, its clinical effectiveness remains limited by poor drug delivery efficiency, severe adverse effects, and emerging chemoresistance. To overcome these limitations, a triple‐drug co‐delivery system (NP3) is designed, encapsulating Cis prodrug (Cis(IV)), curcumin (Cur), and manganese ions within reactive oxygen species (ROS)‐responsive nanoparticles (NPs). NP3 efficiently accumulated at tumor sites and rapidly released its therapeutic payload upon endocytosis, triggered by abundant intracellular ROS. After NP3 degradation, Cis in combination with Cur induced significant DNA damage. This DNA debris subsequently activated the cGAS‐STING pathway, enhancing tumor immunogenicity. Additionally, manganese ions functioned as immune adjuvants, further amplifying cGAS‐STING activation. Consequently, NP3 promoted dendritic cell (DC) maturation, enhanced the infiltration of CD8+ T‐cells, and concurrently decreased the infiltration of immunosuppressive cells. In an OS mouse model, combining NP3 with anti‐PD‐L1 treatment markedly improved both tumor suppression and immune system activation. RNA sequencing analysis demonstrated that NP3 synergistically promoted tumor regression by concurrently inducing pro‐apoptotic signaling and immune responses. In conclusion, this study presents an innovative therapeutic strategy combining targeted chemotherapy delivery with robust antitumor metalloimmunotherapy, offering a promising therapeutic approach for OS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NucleotidyltransferasesOsteosarcomaNanoparticlesReactive Oxygen SpeciesCisplatinCurcuminMembrane ProteinsImmunotherapyBone NeoplasmsAnimalsMiceHumansCell Line, TumorSignal TransductionAntineoplastic AgentsFemaleMice, Inbred BALB CManganeseSTING Protein

Stichwörter der Autor:innen

cGAS‐STINGcisplatinmanganesemetalloimmunotherapyosteosarcoma

Substanzen

NucleotidyltransferasesReactive Oxygen SpeciesCisplatinCurcuminMembrane ProteinsSTING1 protein, humanAntineoplastic AgentsManganeseSTING Protein

Autor:innen und Institutionen

  • Senior Department of Orthopedics, Chinese PLA General Hospital, Beijing, P. R. China.
  • Medical School of Chinese PLA, Beijing, P. R. China.
  • Senior Department of Pediatrics, Chinese PLA General Hospital, Beijing, P. R. China.
  • Department of Anesthesiology, The Fourth Medical Center of PLA General Hospital, Beijing, P. R. China.
  • Department of Stomatology, The First Medical Center of PLA General Hospital, Beijing, P. R. China.

ORCID-Profile: Jianxiong Li

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wu, Y., Han, Y., Li, W., Han, X., Wang, W., Bi, J., Zhang, Y., Xiang, D., Gao, H., Hu, N., Bi, W., & Li, J. (2026). Co‐Delivery of Cisplatin and Curcumin via ROS‐Responsive Nanoparticles to Activate the cGAS‐STING Pathway for Osteosarcoma Metalloimmunotherapy. Advanced Healthcare Materials, 15(9). https://doi.org/10.1002/adhm.202504555

Vancouver

Wu Y, Han Y, Li W, Han X, Wang W, Bi J, et al. Co‐Delivery of Cisplatin and Curcumin via ROS‐Responsive Nanoparticles to Activate the cGAS‐STING Pathway for Osteosarcoma Metalloimmunotherapy. Advanced Healthcare Materials. 2026;15(9). doi:10.1002/adhm.202504555

BibTeX
@article{Wu2026,
  author = {Wu, Yanan and Han, Yuchen and Li, Wenchao and Han, Xinli and Wang, Wei and Bi, Jingyou and Zhang, Yinglong and Xiang, Dongquan and Gao, Hongqin and Hu, Nan and Bi, Wenzhi and Li, Jianxiong},
  title = {Co‐Delivery of Cisplatin and Curcumin via ROS‐Responsive Nanoparticles to Activate the cGAS‐STING Pathway for Osteosarcoma Metalloimmunotherapy},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  volume = {15},
  number = {9},
  doi = {10.1002/adhm.202504555}
}
Kostenlos starten →